Key facts
- Cella Medical Solutions’s last known valuation is $30.4M (Jul 2021).
- It has raised $18.0M; the latest was PE Growth/Expansion in Jan 2025.
- Notable investors include INNVIERTE SICC, Lanzadera Accelerator, Moira Capital Partners, TechFounders.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Cella Medical Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Cella Medical Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cella Medical Solutions
Developer of medical planning and guidance technology intended to assist in complex surgeries. The company uses advanced image processing technologies, cloud computing, 3D printing, augmented reality and robotic surgery to reproduce the real anatomy of the patient, thereby helping surgeons to analyze and simulate the operation before carrying it out.
- Sector
- Healthcare
- HQ
- Murcia, Spain
- Founded
- 2016
- Employees
- 68
- Website
- cellams.com/
- Ownership
- Privately Held (backing)
Cella Medical Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cella Medical Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cella Medical Solutions in its N-PORT filings yet. We sweep new filings monthly.